Actualités Aoxing Pharmaceutical Company New (delisted) - AXN | Actions American Stock Exchange

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION...

(25)

OMB APPROVAL OMB Number:3235-0080 Expires: March 31, 2018 Estimated average...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF...

Withdrawal of Registration Statement (ammendment) (aw)

AOXING PHARMACEUTICAL COMPANY, INC. 1098 Foster City Blvd., Suite 106-810 Foster City, CA 94404 September...

Notification That Annual Report Will Be Submitted Late (nt 10-k)

UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE...

Post-effective Amendment to Registration Statement (pos Am)

As filed with the Securities and Exchange Commission on September 26, 2017 ...

Securities Registration Statement (simplified Form) (s-3/a)

As filed with the Securities and Exchange Commission on September 26, 2017 ...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________ F...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________ FORM...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________ FORM...

Quarterly Report (10-q)

United States Securities and Exchange Commission Washington, D. C. 20549 FORM 10‑Q [...

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGT...

Proxy Statement (definitive) (def 14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20...

Amended Quarterly Report (10-q/a)

United States Securities and Exchange Commission Washington, D. C. 20549 FORM 10‑Q/A (Amendmen...

Quarterly Report (10-q)

United States Securities and Exchange Commission Washington, D. C. 20549 FORM 10‑Q...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Aoxing Pharmaceutical Company New (delisted) (AXN)

Outils de qualité professionnelle, pour des investisseurs individuels.

AXN Actualités

Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

(25)

Notice of Effectiveness (effect)

Withdrawal of Registration Statement (ammendment) (aw)

Notification That Annual Report Will Be Submitted Late (nt 10-k)

Post-effective Amendment to Registration Statement (pos Am)

Securities Registration Statement (simplified Form) (s-3/a)

Current Report Filing (8-k)

Current Report Filing (8-k)

Current Report Filing (8-k)

Quarterly Report (10-q)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Proxy Statement (definitive) (def 14a)

Amended Quarterly Report (10-q/a)

Quarterly Report (10-q)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Vendredi fou

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Aoxing Pharmaceutical Company New (delisted) (AXN) Actualités

Aoxing Pharmaceutical Company New (delisted) (AXN)

Outils de qualité professionnelle, pour des investisseurs individuels.

AXN Actualités

Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

(25)

Notice of Effectiveness (effect)

Withdrawal of Registration Statement (ammendment) (aw)

Notification That Annual Report Will Be Submitted Late (nt 10-k)

Post-effective Amendment to Registration Statement (pos Am)

Securities Registration Statement (simplified Form) (s-3/a)

Current Report Filing (8-k)

Current Report Filing (8-k)

Current Report Filing (8-k)

Quarterly Report (10-q)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Proxy Statement (definitive) (def 14a)

Amended Quarterly Report (10-q/a)

Quarterly Report (10-q)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Vendredi fou

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres